FDA Device Center Director Departs; Feigal Oversaw Approval Of Cypher Stent
Executive Summary
CDRH Office of Device Evaluation Director Daniel Schultz, MD, will become acting director of FDA's device center May 1, replacing David Feigal, MD
You may also be interested in...
People In The News: Former Federal Officials On The Move; Changes At Aurinia, Neo, Mallinckrodt, Lilly, And More
Former FDA Commissioner and CMS Administrator Mark McClellan joins the Johnson & Johnson board; former CMS officials Larry Kocot, Mark Hamelburg and Thomas Hutchinson join law firm Epstein Becker & Green; ONCHIT head Farzad Mostashari heads to Brookings; Aurinia names Glickman acting CEO; more personnel moves in this month’s column.
Former FDA device director joins consulting firm
Falls Church-Va. based NDA Partners announces former Center for Device & Radiological Health Director David Feigal, MD, will join as senior partner. Feigal originally joined FDA's Center for Drug Evaluation and Research in 1992; he also worked in the Center for Biologics Evaluation & Research. NDA Partners Chairman Carl Peck, MD, served as CDER director from 1987-1994 and helped recruit Feigal to the agency. Feigal left FDA at the end of April (1"The Pink Sheet" April 19, 2004, p. 5)...
Former FDA device director joins consulting firm
Falls Church-Va. based NDA Partners announces former Center for Device & Radiological Health Director David Feigal, MD, will join as senior partner. Feigal originally joined FDA's Center for Drug Evaluation and Research in 1992; he also worked in the Center for Biologics Evaluation & Research. NDA Partners Chairman Carl Peck, MD, served as CDER director from 1987-1994 and helped recruit Feigal to the agency. Feigal left FDA at the end of April (1"The Pink Sheet" April 19, 2004, p. 5)...